Osong Public Health and Research Perspectives

Comparative Analysis of the Trends in Medical Utilization of Cancer Inpatients in Korea

Hyun-Ju Lee, Sung-Soo Kim

Additional article information

Abstract

Objectives

Cancer has attracted worldwide attention. The incidence and prevalence are increasing, and it is the main cause of death. The purpose of this study was to identify the characteristics of hospitalized cancer patients.

Methods

This study is a secondary data study using the Korean National Hospital Discharge In-depth Injury Survey Data conducted annually by the Korea Centers for Disease Control and Prevention. Using these data, we extracted inpatients who principal diagnosis is cancer for nine years from 2005 to 2013.

Results

According to the analysis, the annual trend of cancer inpatients is steadily increasing. In 2025, it is expected to increase to about 670,000 inpatients. A cancer diagnosis created a change in medical utilization depending on the characteristics of patients and hospital. Men are more at risk of cancer than women. The number of hospital beds and hospital days were inversely proportional to cancer inpatients. There was also a difference in the equity of medical utilization by region. Other cancer management policies should be based on sex.

Conclusion

Populations between the ages of 45 and 64 years should be a priority in cancer policy. Because of the long-term hospitalization of patients with death as the outcome, a terminal cancer patient care facility is needed. These conclusions can provide a basis for various health policies.

Keywords: cancer, inpatients, mortality, length of stay, trends

INTRODUCTION

Worldwide, cancer is a disease with high incidence, morbidity, and mortality rates. In 2012, the global cancer incidence rate was 14 million people, and it is expected to increase to 19.3 million in 2025 [1]. In the United States, cancer is the second cause of death, and about 1.5 million people have diagnosed with cancer annually and 11 million persons living with cancer [2]. According to 2015 statistics on the causes of death in South Korea, cancer is the leading cause of death in both men and women; the mortality rate is 150.8/100,000 people. This statistic is about three times higher than that of heart or cerebrovascular diseases [3]. To date, studies of cancer have been based on clinical aspects such as causes and diagnosis, preventive measures for early detection, and the increase of treatment effectiveness [4,5]. With these efforts, early diagnosis and therapeutic outcomes improve, survival rates increase, and changes in patients’ medical utilization are expected [6,7]. Additionally, the aging population may affect medical utilization. Changes in medical utilization also affect medical expenses, and since cancer is registered as a major serious disease, the patients’ sharing of medical costs has decreased. It is predicted that this will have a significant impact on the increase of national medical expenses [8].

In South Korea, the Korea Central Cancer Registry has announced the results of epidemiological analysis. These include the yearly incidence and mortality rates based on the cancer registration data of medical institutions. Cancer treatment methods vary according to the diagnosis. Furthermore, because of cancer’s characteristics and prolonged recovery period there is higher hospitalization-centered medical utilization after the diagnosis as compared to other diseases. Therefore, it is necessary to conduct a study of the characteristics of medical utilization based on the hospitalization-centered data generated by treatment in the medical institutions. The World Health Organization (WHO) is concerned that treatment is not the method to prevent the cancer crisis; however, there are still insufficient studies to explain the characteristics of diseases based on state-level systematic health data or improve the changing demands for health care for the more vulnerable classes [1]. Thus, we investigated the characteristics of cancer patients based on the multi-year accumulated data of hospitalized patients. Accordingly, in this study we aimed to analyze how the length of stay (LOS), surgery, and mortality rates affected medical utilization, according to the characteristics of the patients, the results of treatment, and the characteristics of the hospitals. Based on this analysis, this study drew health and forensic implications that could be utilized as basic data for future cancer management policy.

MATERIALS AND METHODS

1. Study population

This study investigated the characteristics of Korean patients hospitalized with cancer as their principal diagnosis. This study used the Korean National Hospital Discharge In-depth Injury Survey of discharged patients administered since 2004 by the Center for Disease Control and Prevention. Each year the Korean National Hospital Discharge In-depth Injury Survey extracts a sample of patients from about 170 sample hospitals nationwide and conducts an analysis, applying the weighted value to estimate the number of discharged patients on the national scale [9,10]. This study, also, analyzed hospitalized cancer patients, applying this weighted value. In February 2017, to acquire of the data for this research, the researchers went through the procedure for consent, including the application form for the use of raw materials and the pledge of information security through the Injury Monitoring Business Homepage of Center for Disease Control and Prevention. The data gathered were the extracted records of patients with cancer as their principal diagnosis from the 1.8 million data points from the Korean National Hospital Discharge In-depth Injury Survey accumulated for nine years from 2005 through 2013, using the database program, Microsoft Access (Microsoft, Redmond, WA, USA). The study criteria were patients with the principle diagnosis of C00–C97 code classified as malignant neoplasm in the Korean Standard Classification of Disease (KCD).

2. Measurement

The variables were divided into three parts. First, variables for the characteristics of patients: sex, age, insurance type, and hospitalization route were selected. Second, for characteristics of patients’ discharge the results of treatment and location after discharge were selected. Third, the location and number of beds in the treatment hospital were selected. Additionally, for an analysis of progress by year, the year of hospitalization was used. Lastly, the LOS, surgery, and death were defined as variables of medical utilization.

3. Research model

To investigate the relationships of the characteristics of cancer patients, the discharge, and the hospitals with the variables of medical utilization, LOS, surgery and death, the following research model was set (Figure 1).

4. Data analysis

Data from the Korean National Hospital Discharge In-depth Injury Survey was loaded into the Microsoft Access database, and the variables were merged in rows. The cancer patients were extracted, using Structured Query Language under the condition of the KCD. IBM SPSS Statistics ver. 20.0 (IBM Co., Armonk, NY, USA) was used for statistical analysis. For a comparison of the average LOS according to the characteristics of the patients, the discharge, and the hospitals, independent sample t-test and one-way analysis of variance (ANOVA) were conducted. Additionally, the progressive increase in the number of cancer patients by year was analyzed, using a linear regression model; to analyze the characteristics of surgery and death distribution, a chi-square test was conducted. The sample design of this Korean National Hospital Discharge In-depth Injury Survey is a composite sampling design, which recommends the application of the weighted value for the accurate estimation of patients [10]. This study conducted an analysis, applying the weighted value to all analysis methods.

RESULTS

1. Comparison of general characteristics and LOS

A comparison of the general characteristics of the subjects and the average LOS accordingly were as follows (Table 1). From 2005 through 2013, the estimated number of discharged patients with cancer as the principal diagnosis nationwide was almost four million. Men were 55.49%, about 10% more than women (44.51%). By age divided based on life-cycle, those between 45 and 64 years had the most distribution (43.86%), followed by those between 65 and 74 years (26.54%), those over 75 years (14.93%), those between 19 and 44 years (12.77%), and those under 18 years (1.89%). For insurance type, those covered by National Health Insurance and those covered by Medical Care Assistance were over 90% and about 9%, respectively. For hospitalization route, emergency admission was 21.77%, and outpatient was 77.99%. For the results of treatment, 83.52% of the patients improved, but 8.74% died, and unimproved patients were 7.22%. For location after discharge, 86.35% of the patients went home, but 4.61% were transferred to other hospitals or sent back to the referring hospitals. As for the locations of hospitals in which patients were admitted, the proportion of Seoul, Gyeonggi-do, and Incheon was the highest at 52.12%, followed by Gyeongsang-do (23.70%), Jeolla-do (9.60%), Chungcheong-do (8.75%), Gangwon-do and Jeju-do (5.83%). For the number of beds in the hospitals, most had 500 to 999 beds (46.98%), and there was also a high rate of those with more than 1,000 beds (26.16%). Hospitals with 300 to 499 beds accounted for 14.08%, and those with 100 to 299 beds were 12.79%. The end result was that over 70% of the cancer patients received treatment at hospitals with over 500 beds.

Table 1

An analysis of a comparison of the average LOS according to general characteristics, demonstrated statistically significant differences in all subjects. To examine the main results, there were somewhat more men than women, and by age, the average LOS was highest in 75-year-old patients at 13.10 ± 16.06 days, those aged 65 to 74 years (12.56 ± 16.38 days), those under 18 years (12.38 ± 20.09 days), those aged 45 to 64 years (11.99 ± 16.62 days), and those aged 19 to 44 years (10.87 ± 24.94 days). By insurance type, Medical Care Assistance Type 1 patients were the highest (16.75 ± 31.60 days), followed by Medical Care Assistance Type 2 (15.94 ± 20.33 days), other (14.28 ± 20.47 days), and National Health Insurance (11.69 ± 15.80 days). For hospitalization route, the LOS was much longer in those admitted through emergency at 16.14 ± 20.93 days than outpatient at 11.09 ± 16.73 days. In the results of treatment, patients who died were at 24.64 ± 38.04 days, more than two times higher LOS than the average. By the locations of hospitals, the LOS was the lowest in hospitals located in Seoul, Gyeonggi-do, and Incheon at 11.45 ± 15.76 days, while it was highest in those located in Gyeongsang-do at 13.65 ± 22.89 days. By the number of beds, the LOS in hospitals with 100 to 299 sickbeds was the highest at 13.79 ± 19.29 days, and in those with 1,000 beds was at 10.19 ± 14.21 days, about two days shorter than 12.17 days, the overall average.

2. Progressive increase of cancer patients by year

The results of the progressive increase in cancer patients by year according to the region are in Table 2. The number of discharged patients in 2005 was excessively estimated. Excluding this, there was an increase in the number by more than 300,000 persons in 2013 as compared to that in 2006. To examine the number by region, it was noted that the number of cancer patients in hospitals located in Busan and Daegu decreased, but in all other regions increased.

Table 2

To show this progress of increase visually, a straight linear regression equation was drawn (Figure 2). The drawn regression equation was as following Equation 1. x representing the period was on a monthly basis. R2 representing the explanatory power of the regression equation was 0.4524 ( Equation 2). That is, the explanation power of the regression model to predict the number of discharged cancer patients with the period as an independent variable was 45.24%, which was at a high level, and the regression coefficient of the period x was 97.309, so the progress of increase turned out to be significant.

y = 97.309 x + 31 , 152 + ɛ
(1)
R 2 = 0.4524
(2)

3. Characteristics of operation and death

Surgery and death are treated as the results of medical utilization in the treatment of diseases. This study analyzed them, dividing them as the variables of medical utilization in order to reflect these characteristics of diagnosed cancer patients. First, to analyze the characteristics of the surgery of patients who were hospitalized with cancer, a chi-square test was conducted according to demographic characteristics (Table 3). In all patients, the proportion of patients for surgery was 33.63%. The rate of surgery in women was much higher than in men. It was 41.36% in women while it was 27.42% in men. By age, half of the patients aged 19 to 44 years and 20.84% of elderly patients over 75 years had surgery. However, only 15.68% of patients under 18 years had surgery. For insurance type, most of them were National Health Insurance patients (35.02%), while Medical Care Assistance Type 1 patients were 19.69%. For hospitalization route, outpatient was 39.63%, which was higher than emergency (11.95%). It turned out that 39.31% of patients who improved as a result of treatment had surgery, while only 5.82% of those that died did. By the location of the hospital, 38.79% of the patients in hospitals located in Seoul, Gyeonggi-do, and Incheon had surgery, while only 20.06% of those in Gangwon-do and Jeju-do did. By the number of beds, 43.34% of patients who had treatment in hospitals with more than 1,000 beds had surgery, while only 13.11% of those in hospitals with 100 to 299 beds did, thus, the larger the number of beds, the higher the rate of surgery. All of the above results were statistically significant (p < 0.001).

Table 3

The results of an analysis of the characteristics of the death of hospitalized cancer patients are in Table 4. Differences in demographic characteristics and death distribution were statistically significant (p < 0.001); 7.27% of the women and 9.93% of men died. Further, mortality rates increased with increasing age. In those aged > 75 years, the mortality rate was 14.39%, while in those aged < 18 years, it was 3.32%. By insurance type, the mortality rate of Medical Care Assistance Type 1 patients was 12.43%, while that of National Health Insurance patients was 8.37%. By the location of the hospital, the mortality rate was 6.94% for patients in hospitals located in Seoul, Gyeonggi-do and Incheon, while that of patients in Gyeongsang-do was 11.45%. By the number of beds, the mortality rate was 3.76% in hospitals with 1,000 sickbeds, which was very low, and the mortality increased with the decrease in the number of beds; the mortality rate of patients in hospitals with 100 to 299 beds was 18.88%.

Table 4

DISCUSSION

This study was conducted to clarify the characteristics of medical utilization in cancer patients and to facilitate data-based health policy suggestions, independent of clinical and preventive medical aspects of cancer. The Korean National Hospital Discharge In-depth Injury Survey by the Center for Disease Control and Prevention was data accumulated since 2005 based on the yearly summaries of the discharge of hospitalized patients. Using this data, this study analyzed the characteristics of hospitalized patients with cancer as the principal diagnosis in hospitals with more than 100 beds. Cancer is a disease with high worldwide mortality and morbidity rate, and as the number of surviving patients increases with the development of treatment methods, medical utilization will change greatly [11]. In addition, cancer may have a large impact on the increase in national medical expenses and the burden of diseases for individuals; thus, a study to understand the characteristics of patients hospitalized with cancer, which is necessary for policy suggestions, is timely.

The main results and implications of the study are as follows. The risk of cancer was higher in men than in women in terms of incidence rate, and the medical utilization of hospital treatment was about 10% higher in men than in women. This could be explained by the higher incidence rate. In addition, men showed a relatively higher LOS than women. The surgery rate in women was 41.36%, much higher than the 27.42% in men. Furthermore, for the in-hospital mortality rate, that of men was 9.93%, which was higher than the 7.27% in women. The surgery rate was high because of the high probability of early cancer and great expectation of full recovery. In sum, it was noted that men were more vulnerable to cancer than women were [12]. Therefore, it would be necessary to implement an effective national cancer policy by sex in parallel with this finding. In other words, even for the same cancer, there must be differentiation between men and women in the cancer control policy. With early diagnosis, the ratio of hospitalized patients aged 45 to 64 years was the highest, and with the increase of age, it tended to decrease. However, the LOS was highest in patients over 75 years. In terms of prevention, like early diagnosis, it is judged that the state should develop a cancer control project with a middle-aged class aged 45 to 64 years, and this suggests that it is necessary for medical institutions to control the elderly patients’ LOS. Of the hospitalized cancer patients 50.30% who had surgery were in aged 19 to 44 years, and surgery tended to decrease with the increase of age, but with the increase of age, the mortality rate also increased [13]. Additionally, the LOS was more than two times higher in patients who died than in those who did not, which supported the basis for the necessity of a policy for the care of terminally ill cancer patients such as hospice care [14,15]. By hospitalization route, in emergency patients, the LOS was longer, but the surgery rate was lower. On the other hand, mortality was higher in emergency patients. Since these major serious diseases directly lead to death because of complications, policy considerations of local hub special hospitals for cancer patients should proceed. Cancer patients’ hospital treatment was concentrated in the capital region, according to the location of hospitals, and their LOS was low. In addition, the surgery rate was high, but the mortality rate was low in hospitals in the capital region. This is mainly because the medical institutions that effectively treat major diseases like tertiary general hospitals are concentrated in the capital region [16]. This suggests that it is necessary to promote the fairness of cancer treatment between regions. For the number of beds in the hospitals that treated hospitalized cancer patients, over 70% were large hospitals with more than 500 beds, and the LOS was low. The greater the number of hospital beds, the higher the surgery rate became, but the mortality rate sharply dropped, so cancer patients’ preference for large hospitals was confirmed. Treatment methods and early detection of cancer have been developed, but in terms of recognition, the phenomenons in which patients are concentrated in large hospitals in the capital region remain because of anxiety about the results of treatment. Thus, it is necessary to tighten a medical quality management policy that can reduce the regional gap. In addition, it is necessary to implement a policy so that regional equity is secured in the allocation of medical resources. Further, we observed a steadily progressive increase in the number of hospitalized cancer patients. This is consistent with WHO that has predicted that the number of cancer patients would greatly increase to 19.3 million persons in 2025 [1]. As a result of an estimation of a nonlinear equation in a time-series analysis, it is expected that the number of hospitalized cancer patients, will increase by 37% from 490,000 in 2013 to 670,000 in 2025. It is necessary to get ready for the fiscal crisis because of changes in major diseases like cancer as well as the economic burden because of population changes.

Suggestions and implications for health policy were discussed based on the results of the study. The Korean database for this study was based on the system for the survey with discharged patients in developed countries such as the United States and Australia. By the research characteristic of the use of secondary data, this study has a limitation that it is difficult to include the factors that can reflect the characteristics of cancer. However, as a result of a statistical analysis reflecting the weighted value based on a composite sampling design, it is possible to estimate the number of hospitalized patients on the national scale, so it has a value for its utilization in policy research on various diseases for the future. Subsequent studies should conduct in-depth analysis according to various factors of cancer and associated diseases.

Article information

Osong Public Health and Research Perspectives.Oct 31, 2017; 8(5): 342-350.
Published online 2017-10-31. doi:  10.24171/j.phrp.2017.8.5.08
aDepartment of Health Administration, Jungwon University, Goesan, Korea
bDepartment of Healthcare Management, Cheongju University, Cheongju, Korea
Corresponding author: Sung-Soo Kim, E-mail: sungskim@cju.ac.kr
Received: August 16, 2017.
Revised: September 29, 2017.
Accepted: October 9, 2017.
Articles from Osong Public Health and Research Perspectives are provided here courtesy of Osong Public Health and Research Perspectives

References

  • Gulland A. Global cancer prevalence is growing at “alarming pace,” says WHO, editors. BMJ 2014;348:g1338. https://doi.org/10.1136/bmj.g1338
  • Huang ME, Sliwa JA. Inpatient rehabilitation of patients with cancer: efficacy and treatment considerations, editors. PM R 2011;3:746-57. https://doi.org/10.1016/j.pmrj.2011.05.020
  • Statistics Korea, editors. 2015 annual report of causes of deaths. Daejeon: Statistics Korea; 2015.
  • Sadigh G, Carlos RC, Ward KC, et al. Breast cancer screening in patients with newly diagnosed lung and colorectal cancer: a population-based study of utilization, editors. J Am Coll Radiol 2017;14:900-10. https://doi.org/10.1016/j.jacr.2017.01.022
  • Park JK, Park HA. Screening rates of major cancers after a cancer diagnosis in adults in Korea, editors. Korean J Health Promot 2012;12:67-74.
  • Loud JT, Murphy J. Cancer screening and early detection in the 21st century, editors. Semin Oncol Nurs 2017;33:121-8. https://doi.org/10.1016/j.soncn.2017.02.002
  • Clarke TC, Christ SL, Soler-Vila H, et al. Working with cancer: health and employment among cancer survivors, editors. Ann Epidemiol 2015;25:832-8. https://doi.org/10.1016/j.annepidem.2015.07.011
  • Lee YJ. A study on the influences of changes to the co-payment of cancer patients of their uses of medical services, editors. J Korean Pub Policy 2009;11:3-25.
  • Korea Centers for Disease Control and Prevention, editors. Korean national hospital discharge in-depth injury survey. Osong: Korea Centers for Disease Control and Prevention; 2012.
  • Cha SK, Kim SS. The determinant of the length of stay in hospital for Schizophrenic patients: using data from the in-depth injury patient surveillance system, editors. J Digit Converg 2013;11:351-9.
  • Haylock PJ. Advanced cancer: emergence of a new survivor population, editors. Semin Oncol Nurs 2010;26:144-50. https://doi.org/10.1016/j.soncn.2010.05.008
  • Yang Y, Li T, Nielsen ME. Aging and cancer mortality: dynamics of change and sex differences, editors. Exp Gerontol 2012;47:695-705. https://doi.org/10.1016/j.exger.2012.06.009
  • White MC, Holman DM, Boehm JE, et al. Age and cancer risk, editors. Am J Prev Med 2014;46:S7-15. https://doi.org/10.1016/j.amepre.2013.10.029
  • Tjia J, Ellington L, Clayton MF, et al. Managing medications during home hospice cancer care: the needs of family caregivers, editors. J Pain Symptom Manage 2015;50:630-41. https://doi.org/10.1016/j.jpainsymman.2015.06.005
  • Gomes, B, Higginson, IJ, Davies, E. Hospice and palliative care, Quah SR editor. International encyclopedia of public health. Oxford: Academic Press; 2017, pp. 69-76.
  • Kang AG. An analysis of the equity in health service utilization with the regional distribution of health care resources, editors. Korean Soc Secur Stud 2007;23:189-219.

Figure 1

Research model.

Figure 2

Trend analysis of cancer inpatient.

Table 1

Mean comparison of length of stay (LOS) by general characteristics

Variable Subject LOS (day) t or F p-value
Sex Male 2,184,622 (55.49) 12.38 ± 16.75 26.070 < 0.001
Female 1,752,579 (44.51) 11.91 ± 19.12
Age (y) ≤ 18 74,489 (1.89) 12.38 ± 20.09 1,236.094 < 0.001
19–44 502,732 (12.77) 10.87 ± 24.94
45–64 1,726,882 (43.86) 11.99 ± 16.62
65–74 1,045,095 (26.54) 12.56 ± 16.38
≥ 75 588,003 (14.93) 13.10 ± 16.06
Insurance National Health Insurance 3,547,295 (90.10) 11.69 ± 15.80 8,838.533 < 0.001
Type-1 Medicaida 338,949 (8.61) 16.75 ± 31.60
Type-2 Medicaida 23,379 (0.59) 15.94 ± 20.33
Others 27,578 (0.70) 14.28 ± 20.47
Admission route Emergency 856,972 (21.77) 16.14 ± 20.93 27,920.817 < 0.001
Outpatient 3,070,684 (77.99) 11.09 ± 16.73
Others 9,546 (0.24) 14.00 ± 20.87
Treatment outcome Improved 3,288,385 (83.52) 11.09 ± 13.68 66,826.383 < 0.001
Not improved 284,206 (7.22) 9.10 ± 15.70
Death 344,288 (8.74) 24.64 ± 38.04
Others 20,321 (0.52) 18.22 ± 21.19
Disposition Return-home 3,399,643 (86.35) 10.85 ± 13.51 65,702.037 < 0.001
Other hospital 181,694 (4.61) 13.42 ± 19.94
Death 344,288 (8.74) 24.64 ± 38.04
Others 11,576 (0.29) 11.30 ± 13.95
Hospital location Seoul, Gyeonggi, Incheon 2,052,080 (52.12) 11.45 ± 15.76 2,616.644 < 0.001
Chungcheong 344,317 (8.75) 12.85 ± 17.62
Jeolla 378,038 (9.60) 12.16 ± 15.12
Gyeongsang 933,180 (23.70) 13.65 ± 22.89
Gangwon, Jeju 229,586 (5.83) 11.59 ± 15.93
Number of beds 100–299 503,394 (12.79) 13.79 ± 19.29 6,301.467 < 0.001
300–499 554,192 (14.08) 12.73 ± 16.63
500–999 1,849,587 (46.98) 12.67 ± 19.44
≥ 1,000 1,030,028 (26.16) 10.19 ± 14.21
Total 3,937,201 (100.00) 12.17 ± 17.84

Values are presented as number (%) or mean ± standard deviation.

aKorea is eligible for medical assistance if the beneficiary (including foreign nationals) as defined in the National Basic Living Security Act.

Type 1 is fully exempted at the time of admission and Type 2 is responsible for 10% of the cost of care.

Table 2

Regional distribution of cancer inpatient

Region Year Total
2005 2006 2007 2008 2009 2010 2011 2012 2013
Seoul 82,378 58,823 64,750 68,436 74,823 76,373 89,738 90,480 85,805 691,606
Busan 45,895 40,513 29,137 27,854 28,966 22,992 24,096 25,055 22,759 267,267
Daegu 22,796 16,338 16,241 15,779 17,181 19,373 15,508 14,738 14,819 152,773
Incheon 21,877 18,819 15,681 22,995 25,048 30,213 35,975 30,738 33,470 234,816
Gwangju 7,978 6,319 11,352 10,240 11,695 13,225 13,436 13,789 14,797 102,831
Daejeon 10,296 10,389 11,320 15,629 11,399 11,024 11,686 13,373 11,227 106,343
Ulsan 14,625 10,138 10,591 11,347 12,378 11,332 10,287 10,953 11,860 103,511
Gyeonggi 75,738 57,274 57,843 64,715 69,748 82,754 84,388 87,850 90,023 670,333
Gangwon 12,582 9,945 9,819 13,234 17,357 22,962 26,006 27,637 26,273 165,815
Chungbuk 11,276 10,021 12,103 20,840 19,910 22,876 26,463 26,037 28,167 177,693
Chungnam 19,634 16,454 16,222 18,960 18,352 21,984 21,568 25,803 26,942 185,919
Chonbuk 18,577 17,034 16,261 18,718 17,876 17,902 18,615 18,214 17,879 161,076
Chonnam 21,185 17,373 23,122 24,429 23,795 23,527 26,487 28,164 26,619 214,701
Gyeongbuk 31,989 25,235 25,582 26,317 26,567 30,529 27,690 29,113 26,388 249,410
Gyeongnam 51,015 40,840 36,540 35,947 36,059 33,637 33,086 38,143 35,331 340,598
Jeju 6,629 4,128 5,975 16,005 12,568 13,140 14,167 16,878 15,917 105,407
Unknown 1,443 518 381 466 148 560 830 937 1,819 7,102
Total 455,913 360,161 362,920 411,911 423,870 454,403 480,026 497,902 490,093 3,937,201

Table 3

Operation rate of cancer inpatient

Variable Operation x2 (p)
Yes No
Sex Male 599,057 (27.42) 1,585,565 (72.58) 84,663.673 (< 0.001)
Female 724,889 (41.36) 1,027,691 (58.64)
Age (y) ≤ 18 11,681 (15.68) 62,808 (84.32) 137,325.162 (< 0.001)
19–44 252,880 (50.30) 249,853 (49.70)
45–64 638,673 (36.98) 1,088,209 (63.02)
65–74 298,164 (28.53) 746,930 (71.47)
≥ 75 122,548 (20.84) 465,455 (79.16)
Insurance National Health Insurance 1242,314 (35.02) 2,304,981 (64.98) 33,191.483 (< 0.001)
Type-1 Medicaida 66,735 (19.69) 272,214 (80.31)
Type-2 Medicaida 7,501 (32.08) 15,878 (67.92)
Others 7,396 (26.82) 20,182 (73.18)
Admission route Emergency 102,444 (11.95) 754,528 (88.05) 230,475.332 (< 0.001)
Outpatient 1,217,024 (39.63) 1,853,660 (60.37)
Others 4,478 (46.91) 5,068 (53.09)
Treatment outcome Improved 1,292,748 (39.31) 1,995,638 (60.69) 289,492.347 (< 0.001)
Not improved 9,763 (3.44) 274,443 (96.56)
Death 20,036 (5.82) 324,253 (94.18)
Others 1,399 (6.89) 18,922 (93.11)
Disposition Return-home 1,291,218 (37.98) 2,108,424 (62.02) 211,570.745 (< 0.001)
Other hospital 11,831 (6.51) 169,863 (93.49)
Death 20,036 (5.82) 324,253 (94.18)
Others 860 (7.43) 10,716 (92.57)
Hospital location Seoul, Gyeonggi, Incheon 796,089 (38.79) 1,255,991 (61.21) 62,973.989 (< 0.001)
Chungcheong 96,338 (27.98) 247,979 (72.02)
Jeolla 126,762 (33.53) 251,276 (66.47)
Gyeongsang 258,692 (27.72) 674,489 (72.28)
Gangwon, Jeju 46,065 (20.06) 183,521 (79.94)
Number of beds 100–299 65,967 (13.10) 43,7427 (86.90) 154,992.835 (< 0.001)
300–499 147,578 (26.63) 406,614 (73.37)
500–999 663,952 (35.90) 1,185,635 (64.10)
≥ 1,000 446,449 (43.34) 583,579 (56.66)
Total 1,323,946 (33.63) 2,613,255 (66.37)

Values are presented as number (%).

aKorea is eligible for medical assistance if the beneficiary (including foreign nationals) as defined in the National Basic Living Security Act.

Type 1 is fully exempted at the time of admission and Type 2 is responsible for 10% of the cost of care.

Table 4

Mortality of cancer inpatient

Variable Mortality x2 (p)
Yes No
Sex Male 216,830 (9.93) 1,967,792 (90.07) 8,575.234 (< 0.001)
Female 127,458 (7.27) 1,625,121 (92.73)
Age (y) ≤ 18 2,469 (3.32) 72,019 (96.68) 38,114.345 (< 0.001)
19–44 25,366 (5.05) 477,366 (94.95)
45–64 132,513 (7.67) 1,594,369 (92.33)
65–74 99,310 (9.5) 945,785 (90.5)
≥ 75 84,630 (14.39) 503,373 (85.61)
Insurance National Health Insurance 296,936 (8.37) 3,250,359 (91.63) 6,639.601 (< 0.001)
Type-1 Medicaida 42,129 (12.43) 296,820 (87.57)
Type-2 Medicaida 2,068 (8.85) 21,311 (91.15)
Others 3,155 (11.44) 24,423 (88.56)
Admission route Emergency 200,659 (23.41) 656,312 (76.59) 295,435.605 (< 0.001)
Outpatient 143,196 (4.66) 2,927,488 (95.34)
Others 433 (4.54) 9,113 (95.46)
Treatment outcome Improved - 3,288,385 (100) NA
Not improved - 284,206 (100)
Death 344,288 (100) -
Others - 20,321 (100)
Disposition Return-home - 3,399,643 (100) NA
Other hospital - 181,694 (100)
Death 344,288 (100) -
Others - 11,576 (100)
Hospital location Seoul, Gyeonggi, Incheon 142,514 (6.94) 1,909,567 (93.06) 19,504.613 (< 0.001)
Chungcheong 36,910 (10.72) 307,407 (89.28)
Jeolla 33,833 (8.95) 344,205 (91.05)
Gyeongsang 106,813 (11.45) 826,368 (88.55)
Gangwon, Jeju 24,220 (10.55) 205,367 (89.45)
Number of beds 100–299 95,053 (18.88) 408,341 (81.12) 113,499.359 (< 0.001)
300–499 72,310 (13.05) 481,882 (86.95)
500–999 138,174 (7.47) 1,711,413 (92.53)
≥ 1,000 38,752 (3.76) 991,276 (96.24)
Total 344,288 (8.74) 3,592,913 (91.26)

Values are presented as number (%).

NA, not available.

aKorea is eligible for medical assistance if the beneficiary (including foreign nationals) as defined in the National Basic Living Security Act.

Type 1 is fully exempted at the time of admission and Type 2 is responsible for 10% of the cost of care.